Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
28 February, 2024 18:10 IST
Supernus Pharmaceuticals first-quarter profit jumps 113.41 percent on a YOY basis
Source: IRIS | 12 May, 2017, 05.11PM

Powered by IRIS XBRL Data
Rating: NAN / 5 stars.
Comments  |  Post Comment


Supernus Pharmaceuticals, Inc. (SUPN) has reported an 113.41 percent jump in profit for the quarter ended Mar. 31, 2017. The company has earned $10.30 million, or $0.19 a share in the quarter, compared with $4.82 million, or $0.08 a share for the same period last year.

Revenue during the quarter surged 30.28 percent to $57.58 million from $44.19 million in the previous year period. Gross margin for the quarter contracted 52 basis points over the previous year period to 94.88 percent. Total expenses were 70.84 percent of quarterly revenues, down from 85.43 percent for the same period last year. This has led to an improvement of 1459 basis points in operating margin to 29.16 percent.

Operating income for the quarter was $16.79 million, compared with $6.44 million in the previous year period.

"We are excited about the launch of Trokendi XR in migraine, and are very encouraged by the early IMS prescription data. We continue to believe that the migraine indication should allow us to realize the full potential of Trokendi XR," said Jack Khattar, president and chief executive officer of Supernus Pharmaceuticals. "Trokendi XR, with its novel formulation, provides full 24 hour coverage for patients with smooth pharmacokinetics compared to immediate-release topiramate products, making it an important new prophylactic treatment option for adult and adolescent patients suffering from migraine headache."

For financial year 2017, Supernus Pharmaceuticals, Inc. forecasts revenue to be in the range of $265 million to $275 million. The company forecasts operating income to be in the range of $75 million to $80 million.


Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]
 Post Comment
Name Email
Comment
Security Code type    into this box
US Equities
Innodata Isogen swings to first-quarter loss on a YOY basis - 10-Jul-2017 03:29
Echelon Corp first-quarter loss widens on a YOY basis - 09-Jul-2017 20:32
Diversicare Healthcare Services swings to first-quarter profit on a YOY basis - 09-Jul-2017 19:51
Dextera Surgical third-quarter loss widens on a YOY basis - 09-Jul-2017 18:20
Open Text Corp third-quarter earnings plunge by 68.72 percent on a YOY basis - 09-Jul-2017 15:17
NAPCO Security Technologies third-quarter earnings decline by 12.19 percent on a YOY basis - 09-Jul-2017 14:31
Patriot National Bancorp first-quarter profit jumps 165.75 percent on a YOY basis - 09-Jul-2017 13:29
Patriot National Bancorp first-quarter profit jumps 165.75 percent on a YOY basis - 09-Jul-2017 13:29
Alaska Communications Systems Group swings to first-quarter loss on a YOY basis - 09-Jul-2017 12:00
Delcath Systems first-quarter loss widens on a YOY basis - 08-Jul-2017 18:33
Edgewater Technology first-quarter loss widens on a YOY basis - 08-Jul-2017 16:21
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer